Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A panelist discusses how the POD1UM-303 randomized phase 3 trial demonstrated that adding retifanlimab (a PD-1 inhibitor) to ...

A panelist discusses how the most effective therapy for squamous cell anal carcinoma is prevention through human ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...

In a conversation with Managed Healthcare Executive, Michael Abrams, M.A., managing partner at Numerof & Associates, painted ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and ...

To prepare for CMS’ new risk adjustment data validation (RADV) strategy, Medicare Advantage plans must take a coordinated, ...

A panelist discusses how the historical standard of care for metastatic squamous cell anal carcinoma evolved from ...